$BMTM
Bright Mountain Media, Inc.

2023 Q4 Form 10-Q Financial Statement

#000162828023038877 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $15.14M $15.29M
YoY Change 193.47% 191.55%
Cost Of Revenue $9.707M $11.93M
YoY Change 250.81% 284.99%
Gross Profit $5.436M $3.362M
YoY Change 127.16% 56.66%
Gross Profit Margin 35.9% 21.99%
Selling, General & Admin $6.958M $4.121M
YoY Change 92.26% 24.01%
% of Gross Profit 128.0% 122.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $595.0K $860.0K
YoY Change 49.12% 115.46%
% of Gross Profit 10.95% 25.58%
Operating Expenses $7.599M $4.121M
YoY Change 109.17% 24.01%
Operating Profit -$2.163M -$17.02M
YoY Change 74.44% 1345.88%
Interest Expense -$2.978M -$8.000K
YoY Change 68.44% -98.95%
% of Operating Profit
Other Income/Expense, Net $22.00K -$2.749M
YoY Change -79.05% 270.99%
Pretax Income -$5.930M -$19.77M
YoY Change 104.27% 930.6%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.930M -$19.77M
YoY Change 104.13% 930.6%
Net Earnings / Revenue -39.16% -129.29%
Basic Earnings Per Share -$0.12
Diluted Earnings Per Share -$0.03 -$0.12
COMMON SHARES
Basic Shares Outstanding 171.3M shares 171.3M shares
Diluted Shares Outstanding 171.3M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.001M $2.780M
YoY Change 1166.14% 574.76%
Cash & Equivalents $4.001M $2.780M
Short-Term Investments
Other Short-Term Assets $1.057M $810.0K
YoY Change 76.17% 5.33%
Inventory
Prepaid Expenses $1.000M
Receivables $14.68M $16.16M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.74M $19.75M
YoY Change 338.5% 288.48%
LONG-TERM ASSETS
Property, Plant & Equipment $505.0K $176.0K
YoY Change 1162.5% 375.68%
Goodwill $7.785M $8.349M
YoY Change -60.37% -57.5%
Intangibles $16.19M
YoY Change 230.86%
Long-Term Investments
YoY Change
Other Assets $156.0K $187.0K
YoY Change 13.87% -22.08%
Total Long-Term Assets $23.68M $25.22M
YoY Change -4.13% 0.09%
TOTAL ASSETS
Total Short-Term Assets $19.74M $19.75M
Total Long-Term Assets $23.68M $25.22M
Total Assets $43.42M $44.98M
YoY Change 48.69% 48.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.14M $10.41M
YoY Change 99.7% 35.53%
Accrued Expenses $474.0K $370.0K
YoY Change 15.33% -84.94%
Deferred Revenue $4.569M $4.489M
YoY Change 519.95% 350.7%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.672M $4.790M
YoY Change 15.1% 69.14%
Total Short-Term Liabilities $30.80M $28.39M
YoY Change 72.55% 59.29%
LONG-TERM LIABILITIES
Long-Term Debt $58.72M $56.72M
YoY Change 133.92% 139.87%
Other Long-Term Liabilities $564.0K $364.0K
YoY Change 76.8% 9.31%
Total Long-Term Liabilities $59.28M $364.0K
YoY Change 133.2% -98.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.80M $28.39M
Total Long-Term Liabilities $59.28M $364.0K
Total Liabilities $90.08M $85.75M
YoY Change 108.18% 105.12%
SHAREHOLDERS EQUITY
Retained Earnings -$149.8M -$143.9M
YoY Change 31.06% 29.17%
Common Stock $1.721M $1.721M
YoY Change 14.43% 14.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $220.0K $220.0K
YoY Change 0.0% 0.0%
Treasury Stock Shares 825.2K shares
Shareholders Equity -$46.67M -$40.77M
YoY Change
Total Liabilities & Shareholders Equity $43.42M $44.98M
YoY Change 48.69% 48.51%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$5.930M -$19.77M
YoY Change 104.13% 930.6%
Depreciation, Depletion And Amortization $595.0K $860.0K
YoY Change 49.12% 115.46%
Cash From Operating Activities $1.222M -$2.290M
YoY Change -5191.67% 335.87%
INVESTING ACTIVITIES
Capital Expenditures $4.000K $10.00K
YoY Change -71.43% 161.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K -$10.00K
YoY Change -71.43% -361.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.000K 1.730M
YoY Change -87.93% 234.82%
NET CHANGE
Cash From Operating Activities 1.222M -2.290M
Cash From Investing Activities -4.000K -10.00K
Cash From Financing Activities -7.000K 1.730M
Net Change In Cash 1.211M -570.0K
YoY Change -1361.46% 11604.31%
FREE CASH FLOW
Cash From Operating Activities $1.222M -$2.290M
Capital Expenditures $4.000K $10.00K
Free Cash Flow $1.218M -$2.300M
YoY Change -3305.26% 334.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3796000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4489000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28392000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17357000 usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
3098000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4121000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3323000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171285150 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171285150 shares
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
364000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
494000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
269000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
85748000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
43271000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
324000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172126629 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
150444636 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171301454 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149619461 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1721000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1504000 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
220000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101323000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98797000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143903000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114269000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
307000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
117000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-40772000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14071000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44976000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29200000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15289000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5244000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29403000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
14000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14420000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
11927000 usd
us-gaap Gross Profit
GrossProfit
7344000 usd
us-gaap Gross Profit
GrossProfit
6694000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14923000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10616000 usd
CY2023Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
16259000 usd
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
16259000 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q3 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
CY2022Q3 bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
415000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2749000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1053000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5796000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1882000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19767000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2230000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29634000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5804000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-19767000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29634000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5804000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
3000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19767000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2231000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29634000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5807000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
57000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
37000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
190000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
54000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19710000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2194000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29444000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5753000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-17797000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-6071000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1926000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149159461 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149159461 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162670182 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162670182 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149140312 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149140312 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2343000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1024000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2218000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
661000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-942000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-166000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5883000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3187000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14000 usd
CY2023Q2 bmtm Adjustments To Additional Paid In Capital Extinguishment Of Debt
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDebt
670000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
119000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-21119000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-19767000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
57000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-40772000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6724000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2117000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8534000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1458000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
17000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9946000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2230000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-1000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
37000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12102000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29634000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5804000 usd
us-gaap Depreciation
Depreciation
84000 usd
us-gaap Depreciation
Depreciation
24000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
4463000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
44000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1438000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
923000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1943000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1173000 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
16259000 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
115000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
97000 usd
bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
0 usd
bmtm Stock Compensation For Oceanside Shares
StockCompensationForOceansideShares
117000 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
0 usd
bmtm Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
1137000 usd
bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
31000 usd
bmtm Common Stock Issued For Services Rendered
CommonStockIssuedForServicesRendered
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
177000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
87000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
277000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
387000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-573000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-423000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-38000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
0 usd
bmtm Payments For Proceeds From Dividend Payments
PaymentsForProceedsFromDividendPayments
3000 usd
bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
0 usd
bmtm Proceeds From Repayments Of Notes Receivable
ProceedsFromRepaymentsOfNotesReceivable
20000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
8626000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3050000 usd
bmtm Repayment Of Principal On Credit Facility
RepaymentOfPrincipalOnCreditFacility
270000 usd
bmtm Repayment Of Principal On Credit Facility
RepaymentOfPrincipalOnCreditFacility
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8357000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2818000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2464000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-369000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
316000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
781000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2780000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
412000 usd
us-gaap Interest Paid Net
InterestPaidNet
161000 usd
us-gaap Interest Paid Net
InterestPaidNet
96000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
4463000 usd
bmtm Noncash Interest Paid In Kind
NoncashInterestPaidInKind
0 usd
bmtm Non Cash Activity Recognition Of Right Of Use Asset And Operating Lease Liability
NonCashActivityRecognitionOfRightOfUseAssetAndOperatingLeaseLiability
0 usd
bmtm Non Cash Activity Recognition Of Right Of Use Asset And Operating Lease Liability
NonCashActivityRecognitionOfRightOfUseAssetAndOperatingLeaseLiability
380000 usd
bmtm Non Cash Activity Issuance Of Common Shares To Settle Share Liability
NonCashActivityIssuanceOfCommonSharesToSettleShareLiability
0 usd
bmtm Non Cash Activity Issuance Of Common Shares To Settle Share Liability
NonCashActivityIssuanceOfCommonSharesToSettleShareLiability
162000 usd
us-gaap Stock Issued1
StockIssued1
1926000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
bmtm Noncash Activity Issuance Of Debt For Acquisition Financing
NoncashActivityIssuanceOfDebtForAcquisitionFinancing
19874000 usd
bmtm Noncash Activity Issuance Of Debt For Acquisition Financing
NoncashActivityIssuanceOfDebtForAcquisitionFinancing
0 usd
bmtm Noncash Or Party Noncash Acquisition Extinguishment
NoncashOrPartyNoncashAcquisitionExtinguishment
670000 usd
bmtm Noncash Or Party Noncash Acquisition Extinguishment
NoncashOrPartyNoncashAcquisitionExtinguishment
0 usd
CY2023Q3 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
16 worker
us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
36 worker
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
85000 usd
us-gaap Restructuring Charges
RestructuringCharges
322000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000 usd
bmtm Service Agreement Period
ServiceAgreementPeriod
P5Y
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143900000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5900000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3200000 usd
bmtm Working Capital Deficit
WorkingCapitalDeficit
8600000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of our unaudited consolidated financial statements as well as reported amounts of revenue and expenses during the periods presented. Our unaudited consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates included in the accompanying unaudited consolidated financial statements include, valuation of goodwill and intangible assets, allowance for doubtful accounts, estimates of amortization period for intangible assets, estimates of depreciation period for property and equipment, litigation reserves, the valuation of equity-based transactions, valuation of the Center Lane Senior Secured Facility carrying value regarding debt modification or extinguishment,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and the valuation allowance on deferred tax assets.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Concentrations of Credit Risk</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. In addition, the Company maintains various bank accounts in Thailand and Israel, with some level of insurance. We perform periodic evaluations of the relative credit standing of financial institutions. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain an allowance for doubtful accounts receivable based upon the expected collectability of accounts receivable balances.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company generates revenue as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">•</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">selling of advertisements placed on the Company’s owned and managed sites, as well as from advertisements placed on partner websites, for which the Company earns a share of the revenue;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">•</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">facilitating the real-time buying and selling of advertisements at scale between networks of buyers, known as DSPs and sellers known as SSPs;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:13.8pt">serving advertisers and agencies by providing access to premium inventory and leveraging data to optimize programmatic campaigns, where revenue is derived from the planning and execution of creative and media marketing campaigns; and</span></div>•providing primary research and secondary research, competitive intelligence and expert insight to address customer's strategic issues, where revenue is primarily derived from providing a single integrated service for research.
CY2023Q3 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
2 customer
CY2022Q3 bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
2 customer
bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
bmtm Number Of Customers Exceeding10 Revenue
NumberOfCustomersExceeding10Revenue
1 customer
CY2023Q3 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
2 customer
CY2023Q1 bmtm Number Of Customers Exceeding10 Receivable
NumberOfCustomersExceeding10Receivable
1 customer
CY2023Q3 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
0 vendor
CY2023Q1 bmtm Number Of Vendors Exceeding10 Revenue
NumberOfVendorsExceeding10Revenue
2 vendor
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, reclassification of certain accounts has been made to previously reported amounts to conform to their treatment to the current period. Specifically, the Company identified a reclassification of commissions from general and administrative expenses to cost of revenue on the consolidated statements of operations, reclassification between note receivable to prepaid expense and other current assets, website acquisition assets to intangible assets, as well as a reclassification between accrued expenses to other liabilities on the consolidated balance sheets. These reclassifications had no impact on the previously reported net loss for the three and nine months ended September 30, 2022.</span></div>
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
14430000 usd
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
3447000 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2239000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
724000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
16669000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4171000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
508000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
586000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16161000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3585000 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
204000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-136000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
177000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
87000 usd
CY2023Q3 us-gaap Prepaid Insurance
PrepaidInsurance
111000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1000 usd
CY2023Q3 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
0 usd
CY2022Q4 bmtm Prepaid Consulting Service Agreements
PrepaidConsultingServiceAgreements
285000 usd
CY2023Q3 bmtm Prepaid Software
PrepaidSoftware
65000 usd
CY2022Q4 bmtm Prepaid Software
PrepaidSoftware
176000 usd
CY2023Q3 us-gaap Deposits Assets
DepositsAssets
187000 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
137000 usd
CY2023Q3 bmtm Prepaid Subscriptions
PrepaidSubscriptions
382000 usd
CY2022Q4 bmtm Prepaid Subscriptions
PrepaidSubscriptions
0 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
255000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
138000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1000000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
737000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
187000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
813000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2363000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
389000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2187000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
349000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
38000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
84000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2500000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
2500000 usd
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16189000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4510000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
829000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
387000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
547000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2187000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1978000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1771000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1771000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
7935000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16189000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
19645000 usd
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
2425000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13721000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
8349000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13700000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10409000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8585000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
283000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
380000 usd
CY2023Q3 bmtm Publisher Cost Current
PublisherCostCurrent
1332000 usd
CY2022Q4 bmtm Publisher Cost Current
PublisherCostCurrent
559000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
801000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
677000 usd
CY2023Q3 bmtm Subcontractor Current
SubcontractorCurrent
1461000 usd
CY2022Q4 bmtm Subcontractor Current
SubcontractorCurrent
0 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
89000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
116000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14375000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10317000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
692000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
692000 usd
CY2023Q3 bmtm Project Advance Expense Current
ProjectAdvanceExpenseCurrent
3051000 usd
CY2022Q4 bmtm Project Advance Expense Current
ProjectAdvanceExpenseCurrent
0 usd
CY2023Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1270000 usd
CY2022Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1107000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1000 usd
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
5061000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
1838000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
364000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
494000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4697000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1344000 usd
CY2020Q2 bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
250000 usd
bmtm Repayment Of Loans Percentage
RepaymentOfLoansPercentage
0.025
CY2023Q2 bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
18 amendment
CY2023Q3 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
124000 usd
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
285000 usd
CY2022Q3 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
55000 usd
us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
96000 usd
CY2023Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
140000 usd
CY2023Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4716000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
4860000 usd
CY2023Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
56723000 usd
CY2022Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
25101000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
61439000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
29961000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6597000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
3148000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
68036000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
33109000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
26334000 usd
CY2023Q3 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
29816000 usd
CY2022Q4 bmtm Debt Instruments Additional Draw
DebtInstrumentsAdditionalDraw
3050000 usd
CY2023Q3 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
918000 usd
CY2022Q4 bmtm Debt Instrument Exit And Other Fee
DebtInstrumentExitAndOtherFee
621000 usd
CY2023Q3 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
4463000 usd
CY2022Q4 bmtm Debt Instrument Interest Capitalized
DebtInstrumentInterestCapitalized
3104000 usd
CY2023Q3 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
35197000 usd
CY2022Q4 us-gaap Debt Instrument Repurchase Amount
DebtInstrumentRepurchaseAmount
6775000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
270000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
68036000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
33109000 usd
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
35500000 usd
bmtm Adjustments To Additional Paid In Capital Extinguishment Of Debt
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDebt
670000 usd
CY2023Q3 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
37991000 usd
CY2023Q3 bmtm Line Of Credit Facility Agency Fee
LineOfCreditFacilityAgencyFee
140000 usd
CY2023Q3 bmtm Line Of Credit Facility Exit Fee
LineOfCreditFacilityExitFee
4583000 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
34051993 shares
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6000000 usd
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
500000 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2179000 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
745000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4748000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2137000 usd
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
590000 usd
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
305000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1428000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
913000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2769000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1050000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
6176000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
3050000 usd
CY2020Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.015
CY2020Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.18
CY2022Q3 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
650000 usd
CY2022Q3 bmtm Legal Settlement Period
LegalSettlementPeriod
P50M
CY2023Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
520000 usd
CY2023Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
156000 usd
CY2023Q3 us-gaap Loss Contingency Accrual Carrying Value Noncurrent
LossContingencyAccrualCarryingValueNoncurrent
364000 usd
CY2023Q3 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
1100000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15289000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5244000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29403000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14420000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15289000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5244000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29403000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14420000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1162000 usd
bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
14670000 usd
CY2022 bmtm Deferred Revenue Invoice Amount
DeferredRevenueInvoiceAmount
588000 usd
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
4695000 usd
CY2022 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
0 usd
bmtm Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
15613000 usd
CY2022 bmtm Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
1013000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4489000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
737000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6517660 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.12
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
5803200 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.09
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
P9Y4M24D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
90000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
869375 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
217125 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.07
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11144360 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1811522 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.30
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
9332838 shares
bmtm Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedWeightedAverageExercisePrice
0.08
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedWeightedAverageRemainingContractualTerm1
P9Y4M24D
bmtm Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedIntrinsicValue1
0 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
344000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.04
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0388
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0273
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0293
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2022Q3 bmtm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
5803200 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
5070433 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149984636 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171301454 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149159461 shares
CY2023Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
825175 shares
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
13700000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
2500000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
321000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
317000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
39000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
120000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
6000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
6000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
95000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
95000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
321000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
367000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
269000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
319000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
317000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
357000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2023Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1500000 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
21401993 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1926000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
90000 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
0 shares
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
20000 shares
CY2023Q3 bmtm Stock Issued During Period Common Stock Value Period Increase Decrease
StockIssuedDuringPeriodCommonStockValuePeriodIncreaseDecrease
0 usd
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
21681993 shares
bmtm Stock Issued During Period Common Stock Value Period Increase Decrease
StockIssuedDuringPeriodCommonStockValuePeriodIncreaseDecrease
1958000 usd
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
174253 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
279000 usd
CY2021 bmtm Number Of Shareholders
NumberOfShareholders
3 shareholder
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25582729 shares
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
19921000 usd
bmtm Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
10415587 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
15300000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
35998316 shares
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
26692000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
172126629 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-19767000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2230000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29634000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5804000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
3000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19767000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2231000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149159461 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149159461 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162670182 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
162670182 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149140312 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149140312 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25582729 shares
bmtm Debt Instrument Number Of Amendments
DebtInstrumentNumberOfAmendments
19 amendment
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
CY2023Q3 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 usd

Files In Submission

Name View Source Status
0001628280-23-038877-index-headers.html Edgar Link pending
0001628280-23-038877-index.html Edgar Link pending
0001628280-23-038877.txt Edgar Link pending
0001628280-23-038877-xbrl.zip Edgar Link pending
bmtm-20230930.htm Edgar Link pending
bmtm-20230930.xsd Edgar Link pending
bmtm-20230930_g1.jpg Edgar Link pending
bmtm-2023x0930x10qxexx311.htm Edgar Link pending
bmtm-2023x0930x10qxexx312.htm Edgar Link pending
bmtm-2023x0930x10qxexx321.htm Edgar Link pending
bmtm-2023x0930x10qxexx322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
bmtm-20230930_lab.xml Edgar Link unprocessable
bmtm-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bmtm-20230930_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bmtm-20230930_cal.xml Edgar Link unprocessable
bmtm-20230930_def.xml Edgar Link unprocessable